Why the study?
Does overexpression of creatine kinase isoforms reduce cell death in response to hypoxia/reoxygenation or anthracycline toxicity in vitro?
Does overexpression of creatine kinase isoforms reduce cell death in response to hypoxia/reoxygenation or anthracycline toxicity in vitro?
Overexpression of creatine kinase isoforms, particularly CKMT2, protects cardiac-relevant cells against hypoxia/reoxygenation injury but not anthracycline toxicity in vitro.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for ischemia-reperfusion protection; leaves open in vivo translation and any role versus anthracycline toxicity.
Zervou et al. (2017) studied this question.